Skip to main content
. 2019 Aug 19;1(3):otz026. doi: 10.1093/crocol/otz026

FIGURE 2.

FIGURE 2.

Study participants were either classified as OSMhigh or OSMlow based on their pretreatment plasma OSM level (≥143.5 pg/mL = OSMhigh). (A) OSMlow patients had a higher rate of W52 biochemical remission (fecal calprotectin <250 µg/g) and (B) clinical remission (wPCDAI < 12.5) compared with OSMhigh. Rates of remission were compared by the Fisher exact test.